Loading

JSM Gastroenterology and Hepatology

Rapid Identification of Viable H. pylori Cells in Feces by DVCFISH

Research Article | Open Access

  • 1. Research Institute on Water and Environmental Engineering, Universitat Politècnica de València, Spain
  • 2. Department of Biotechnology, Universitat Politècnica de València, Spain
  • 3. Department of Digestive Diseases and Medicina, Universitat Autònoma de Barcelona, Spain
  • 4. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Spain
+ Show More - Show Less
Corresponding Authors
Yolanda Moreno, Research Institute on Water and Environmental Engineering, IIAMA. Universitat Politècnica de València, Camino de Vera 14, 46022 Valencia, SPAIN; Tel/fax: +34 96 3877090
Abstract

Helicobacter pylori isolation in fecal samples is a less invasive and more comfortable practice than those that require patient endoscopy, particularly in children. However, culture of this pathogen from stools is usually unsuccessful. Other techniques such as PCR or H. pylori Stool Antigen (HpSA) are used to detect the presence of H. pylori in feces; nevertheless, a positive result by using these techniques does not involve viability of the pathogen. Direct Viable Count combined with Fluorescent in situ Hybridization (DVCFISH) technique has been successfully applied to detect viable H. pylori cells in highly contaminated environmental samples. To assess the suitability of DVC-FISH technique to identify viable H. pylori cells in stools, experimentally inoculated feces and fecal samples from infected patients were analyzed. qPCR and culture techniques were also used. Viable H. pylori cells were detected by DVC-FISH in all inoculated samples with a specific DNA/LNA probe. H. pylori colonies were also identified on agar. DVC-FISH gave positive results in all the patients’ fecal samples, while qPCR only detected H. pylori in two patients.

DVC-FISH technique with LNA/DNA probes has the potential to be used as a specific and effective non-invasive method for the detection of viable H. pylori in stools samples. Moreover, our results evidence the presence of viable H. pylori cells in fecal samples from infected patients, supporting the evidence that H. pylori is transmitted via the fecal route.

Citation

Moreno Y, Pérez R, Ramirez MJ, Calvet X, Santiago P, et al. (2015) Rapid Identification of Viable H. pylori Cells in Feces by DVC-FISH. JSM Gastroenterol Hepatol 3(3): 1049.

Keywords

Helicobacter pylori , qPCR , Rapid Urease Test

INTRODUCTION

H. pylori is the cause one of the most common chronic infections in humans [1]. It is estimated that approximately 50% of the world population is infected; however, only about 10-15% of infected individuals will develop peptic ulcer, and in 1-3% gastric cancer will appear.

Currently a range of techniques are being applied for diagnosis, each with their own advantages and disadvantages. Invasive gastroscopic biopsy-based methods, such as the Rapid Urease Test (RUT), histological examination and culture have been widely used to diagnose H. pylori infection [2]. Endoscopy is an expensive procedure, not free of risks, that requires highly qualified personnel to be carried out. It is also an uncomfortable procedure, especially in non-collaborative patients and children. Other non-invasive diagnostic techniques, urea breath test (UBT), stool antigen detection or serology, are also widely used. However, these present some problems, such as being technically demanding, presenting non-optimun specificity or difficulty in assessing the existence of an active infection [3]. Moreover, they do not allow for isolating the bacteria. Thus, no antibiotic resistance tests or genetic characterization can be performed.

Bacteriological culture is a tedious, time-consuming procedure, and unnecessary for the routine diagnosis of H. pylori infection in the majority of patients. The sensitivity of culture has been reported to vary greatly among laboratories, because H. pylori is very fastidious, and even experienced laboratories recover it from only from 50% to 70% of infected biopsies [4]. However, culture is the most specific way to diagnose H. pylori infection. It allows for testing of the antibiotic sensitivity of isolated strains, enables us to have a better understanding of the pathogen-host interaction and facilitates to determine the main epidemiologic features relative to this pathogen [4]. Especially, culture from clinical or environmental samples is crucial to demonstrate the potential of this sample to act as a transmission vehicle, as the bacterium must be present in a viable form to be infective.

There is much controversy regarding the transmission pathways of H. pylori [5]. Different routes have been proposed, such as oral-oral, fecal-oral and indirect transmission via water or even foods. H. pylori have been found in feces, saliva or vomit [4] and may even be acquired through other routes [6].

Among all the transmission mechanisms, fecal-oral transmission seems to be one of the most relevant, especially in developing countries, as suggested by different epidemiological studies [7]. H. pylori, present in gastric mucosa, is constantly eliminated to the gut via gastric juice. Thus, feces or any material contaminated by them, such as water, vegetables or milk, could be the vehicle of transmission for the infection [8].

The existence of a fecal-oral route means that the bacterium should be isolated from stool specimens. Extensive indirect evidence suggests that the organism is present in feces. Momtaz et al. [9] detected H. pylori in different areas of the digestive tract (10, 72% in saliva, 77, 66% in gastric biopsies and 71, 67% in feces). By PCR, H. pylori DNA has been detected it in fecal samples [4]. Equally H. pylori Stool Antigen (HpSA) test supports the view that H. pylori is excreted in the feces. Even so, there is still the doubt about how H. pylori can remain viable. The bacterium is sensitive to bile, so it should not be able to survive during its transit through the enteric tract [10].

A positive result obtained by PCR or antigen tests does not mean that the pathogen maintains its viability in the feces, as it may just be that they are detecting the antigen or DNA from dead bacteria. Therefore, except for some reports of culture from the stool, there is little evidence that H. pylori survives in the colon.

Attempts to culture H. pylori from feces have had limited success. Recovery from stool is very difficult because of the complex nature of the sample: stools are rich in bile salts, hydrolytic enzymes [11] and other commensal biota hampering the growth of H. pylori [2]. It may also be possible that the bacterium is viable but not culturable (VBNC) due to the stressful environmental conditions during its passage along the intestinal tract.

The use of sensible and specific methods for detecting viable cells of H. pylori in feces could be an alternative to invasive diagnostic methods, particularly for children, as feces can be comfortably obtained at home and without active collaboration [12]. Moreover, these techniques could facilitate epidemiological studies about its mode of transmission.

Direct Viable Count combined with Fluorescent in situ Hybridization (DVC-FISH) has been previously used to detect and identify viable H. pylori cells in water samples [13] and it can be easily applied to feces. Thus, the objective of this work was to assess the suitability of DVC-FISH technique to detect and identify viable H. pylori cells in fecal samples. HpSA, qPCR and culture techniques were also used for comparison. 

MATERIAL AND METHODS

Helicobacter pylori Strains

H. pylori NCTC 11637 and B67 (isolated from a gastric human biopsy) strains were used for inoculation assays. Bacteria were grown on Columbia agar plates (Difco Laboratories, Detroit, MI, USA) supplemented with 10% horse blood, Dent selective supplement (Oxoid) and 0.0025% sodium pyruvate, at 37o C under microaerobic conditions.

Inoculated faecal samples

Exponential (48 h) cultures of both H. pylori strains were used to spike H. pylori-free faecal samples. Briefly, cultures from both NCTC 11637 and B67 strains were resuspended in PBS buffer (130 mmol/L sodium chloride, 10 mmol/L sodium phosphate, pH 7.2), diluted to give 107-108 CFU/mL, and used to inoculate 1 g of feces mixed previously with 9 mL of PBS. Samples were shaken for 5 min at 160 rpm to enable bacteria to attach to fecal particles. One mL aliquots of each inoculated sample were taken for later processing by q-PCR and DVC-FISH. One hundred µl samples were also spread onto Dent selective agar. In addition, 200 µl were inoculated on a 0.65 µm membrane (Whatman, Maidstone, England) and placed onto selective agar. Plates were incubated at 37 ° C under microaerobic conditions. After 24 h incubation, membranes of the plates were removed and incubated further for 48 -72h. Presumptive colonies were identified by FISH and qPCR as described below.

q-PCR

DNA from 1 mL sample was isolated by using the GeneJetTM Genomic DNA Purification kit (Fermentas, Germany) according to the manufacturer´s instructions.

Two µl of the eluted DNA was used for specific H. pylori SYBR Green-based qPCR with VacA primers, described previously, [14] to amplify a 372-bp fragment from the vacA gene of H. pylori [14]. Real time was performed in a final volume of 20 µl containing: 4 µl of LightCycler Fast-Star DNA Master SYBR Green I (Light Cycler Fast Start DNA Master SYBR Green I. Roche Applied Science.), 1.6 µl of MgCl2 (4mM), 0.5 µl of each primer and 2 µl of template. The amplification consisted of an initial DNA denaturation step at 95ºC for 10 minutes, followed by a 40-cycle reaction: 95ºC for 10 seconds, 62ºC for 5 seconds, 72ºC for 16 seconds and after that one cycle of extension at 72ºC for 15 seconds and finally one cycle at 40ºC for 30 seconds.

PCR products were visualized under 1.5 % agarose gel electrophoresis stained with 0.01% GelRed (Biotium, USA)and then purified with the GenElute PCR Clean-Up Kit (Sigma, USA) according to manufacturer’s instructions and subsequently analyzed by sequencing (IBMCP, CSIC). The homology of the amplified sequences with the correspondent H. pylori vacA gene fragment was determined by a BLAST alignment (www.ncbi.nlm. nih.gov/BLAST).

DVC-FISH analysis

One mL of sample was inoculated in 9mL of DVC broth (Brucella broth supplemented with 5% Fetal Bovine Serum (FBS) and 0.5 mg/L novobiocin) supplemented with 0.0025% sodium piruvate and incubated for 24 hours under optimal conditions for H. pylori [15].

After incubation, DVC tubes were centrifuged at 8500 rpm for 8 minutes. The supernatant was removed and the pellet was resuspended in 1 mL of PBS 1X and then fixed for FISH analysis as described for Gram-negative bacteria by Moreno et al. [16]

The fixed samples were deposited on the wells of hybridization slides, air dried and dehidrated by successive immersing in volumes of 50, 80 and 100 % ethanol for 3 minutes each. Fixed samples were subsequently hybridized with LNA- HPY and EUB 338 16S rRNA probes labelled with CY3 and fluoresce in respectively, according to conditions described by Moreno et al. Briefly, hybridization buffer (0.9 M/L NaCl , 0.01 % SDS, 20 mM/L Tris-HCl and 40 % formamide, pH 7.6) containing 50 ng of each probe were deposited on the wells and then, slides were incubated at 46ºC for 2 h in darkness. After washing, hybridized samples were examined with an Olympus microscope BX50 equipped with a 100W mercury high-pressure bulb and set filters U-MWB, U-MWIB and U-MWIG. Color micrographs were taken with a digital camera Olympus DP 12 (Olympus Optical Co., Hamburg, Germany). The fluorescent green intensity signal was measured with Olympus DP Soft program.

Faecal samples

Outpatients sent to the Endoscopy Unit of the Hospital de Sabadell for evaluation of dyspeptic symptoms were recruited for the study. Patients were contacted prior to the endoscopy, and asked to participate. Those who agreed signed informed consent. Patients were instructed to avoid antisecretory drugs during the two weeks before the test and they were asked to bring a faecal sample on the day the endoscopy was performed. Before the endoscopy, a 13[C]-urea breath test (UBT) (UBiTest 100 mg, Otsuka Pharmaceutical Europe Ltd, UK) was performed. During endoscopy, two antral biopsies for histology and one for rapid urease test (RUT, JATROX HP test CHR Heim Arzneimittel GmbH, Germany) were obtained. A total of 5 faecal samples from infected patients (positive for all tests above described) were also analysed to test the suitability of DVC-FISH technique in order to identify viable H. pylori.

Five grams of fresh faeces were homogenized with 45mL of PBS buffer and vortexed. One mL aliquots were processed for DVC-FISH and qPCR as previously described for inoculated samples. One hundred µL was also analysed directly by culture on Dent agar under the above describe conditions and 400µL were placed onto a 0.65 µm cellulose acetate membrane filters and deposited on selective agar media as previously described [13]. Samples were also analysed after an enrichment step. Briefly, 10 mL of the homogenized samples were suspended in 20 mL of Dent enrichment broth and incubated under microaerobic conditions at 37ºC for 24 h. After enrichment, aliquots were obtained for further analysis by DVC-FISH, qPCR and culture as for non- enriched samples.

 

 

 

 

 

 

 

 

 

 

 

RESULTS AND DISCUSSION

Histology is one of the most common tests used to detect the H. pylori infection and is considered by most authors the “gold standard” [17]. Nevertheless, it is also an invasive and expensive screening technique. Helicobacter pylori detection in faecal samples is an easier and more comfortable practice than invasive techniques, mainly in children. However, culture of this pathogen from stools is difficult and normally unsuccessful, and colonies confirmation tests are necessary. Other techniques such as PCR or H. pylori Stool Antigen (HpSA) are used to detect the presence of H. pylori in faeces. Nevertheless, a positive result by these techniques does not recognise the viability of the pathogen. This is an important point, as transmission of the bacteria via fecaloral route, although generally admitted, is not fully assessed, due mainly to our lack of knowledge about the cellular state and infectiveness of H. pylori in feces.

In this work we have improved the specific method DVCFISH to use as a non-invasive method to detect the pathogen in infected individuals.

Presumptive H. pylori colonies were observed from both NCTC 11637 and B67 inoculated samples, but in all cases with a high nonspecific microbiota growth on agar plates (Figure 1) Colonies from inoculated faeces were only appreciated on the plates in which the samples were passed through a membrane.

Viable H. pylori cells were detected by DVC-FISH in all samples of inoculated faeces with specific DNA/LNA probe (Figure 2). In spite of the presence of great amount of competitive microbiota, viable (elongated) and non- viable H. pylori cells were easily observed. After enrichment, samples showed an increase of unspecific microbiota, hindering H. pylori identification. Inoculated samples were also qPCR positive directly and yielded negative results after enrichment. These results were in accordance with previous reports about H. pylori detection [18], showing that a previous enrichment step does not favor the detection of the pathogen by qPCR.

As shown with the inoculated samples, some H. pylori presumptive colonies from patient fecal samples were only observed on the plates cultured by membrane technique in 2 out of 4 patients. Colonies could not be purified because of growth of unspecific microbiota on the selective plates. Thus, identification of H. pylori cells within the cultures was only possible by molecular methods such as qPCR and FISH. The low efficiency on H. pylori detection by culture could be due not only to the lack of specificity of culture media but also, the environmental stress on the pathogen through the gastro intestinal tract, which become H. pylori to VBNC state, diminish the pathogen recovery [11]. Other authors have reported the difficulty to culture H. pylori from feces and the need for a pretreatment of the patient prior to the analysis in order to reduce the bile salts content [12].

qPCR analysis detected H. pylori in feces from 2 out of the 4 patients, one of them after enrichment. Although qPCR is a highly sensitive technique, stools are complex mixtures that often contain PCR inhibitors and other commensal bacteria making false-negative and false-positive results a larger problem [19].

DVC-FISH showed the presence of viable H. pylori in all the patients samples according with the results obtained by invasive methods (histology and RUT). It seems that the factors affecting the cultivation of H. pylori in feces do not affect their metabolic activity, thus remaining viable and potentially infective. Although DVC-FISH is not as sensitive as other molecular techniques for less contaminated samples [18], it was more efficient than qPCR in this kind of samples. In addition, this technique incorporated an overview of the habitat and microbiota companion of the species studied, as well as morphology that adopt these bacteria in the feces, allowing for its count.

Thus, DVC-FISH technique would be an effective alternative to culture for the detection of viable cells of H. pylori in feces. It is a less invasive, more comfortable practice and more costeffective than culture from gastric biopsy, and the results could be obtained in 48h, a short time with regard to culture

Moreover, our results evidence the presence of viable H. pylori cells in fecal samples from infected patients, supporting the evidence of the fecal route of H. pylori transmission.

 

 

 

 

 

 

 

 

 

ACKNOWLEDGEMENTS

The work has been funded by AGL2014-53875-R grant (Ministerio de Economía y Competitividad, Spain).

REFERENCES

1. Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ Jr, et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991; 36: 1084-1088.

2. Lopes AI, Vale FF, Oleastro M. Helicobacter pylori infection - recent developments in diagnosis. World J Gastroenterol. 2014; 20: 9299- 9313.

3. Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, et al. Diagnosis of Helicobacter pylori infection: Current options and developments. World J Gastroenterol. 2015; 21: 11221-11235.

4. Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol. 2014; 20: 12847-12859.

5. Engstrand L. Helicobacter in water and waterborne routes of transmission. Symp Ser Soc Appl Microbiol. 2001; : 80S-4S.

6. Prasanthi CH, Prasanthi NL, Manikiran SS, Rama Rao N. Focus on current trends in the treatment of Helicobacter pylori infection: An update. Int J Pharma Sciences. 2011; 9: 42-51.

7. Mentis A, Lehours P, Mégraud F. Epidemiology and Diagnosis of Helicobacter pylori infection. Helicobacter. 2015; 20 Suppl 1: 1-7.

8. Percival SL, Thomas JG. Transmission of Helicobacter pylori and the role of water and biofilms. J Water Health. 2009; 7: 469-477.

9. Momtaz H, Souod N, Dabiri H, Sarshar M. Study of Helicobacter pylori genotype status in saliva, dental plaques, stool and gastric biopsy samples. World J Gastroenterol. 2012; 18: 2105-2111.

10. Itoh M, Wada K, Tan S, Kitano Y, Kai J, Makino I. Antibacterial action of bile acids against Helicobacter pylori and changes in its ultrastructural morphology: effect of unconjugated dihydroxy bile acid. J Gastroenterol. 1999; 34: 571-576.

11. van Tongeren SP, Slaets JP, Harmsen HJ, Welling GW. Fecal microbiota composition and frailty. Appl Environ Microbiol. 2005; 71: 6438-6442.

12. Falsafi T, Valizadeh N, Najafi M, Ehsani A, Khani A, Landarani Z, et al. Culture of Helicobacter pylori from stool samples in children. Can J Microbiol. 2007; 53: 411-416.

13. Moreno Y, Ferrús MA. Specific detection of cultivable Helicobacter pylori cells from wastewater treatment plants. Helicobacter. 2012; 17: 327-332.

14. Santiago P, Moreno Y, Ferrús MA. Identification of Viable Helicobacter pylori in Drinking Water Supplies by Cultural and Molecular Techniques. Helicobacter. 2015; 20: 252-259.

15. Piqueres P, Moreno Y, González A, Hernández J, Ferrús MA. Rapid detection of Helicobacter pylori in vegetables irrigated with contaminated water. Helicobacter. 2006; 9: 511.

16. Moreno Y, Piqueres P, Alonso JL, Jiménez A, González A, Ferrús MA. Survival and viability of Helicobacter pylori after inoculation into chlorinated drinking water. Water Res. 2007; 41: 3490-3496.

17. el-Zimaity HM. Accurate diagnosis of Helicobacter pylori with biopsy. Gastroenterol Clin North Am. 2000; 29: 863-869.

18. Moreno Y, Ferrús MA, Alonso JL, Jiménez A, Hernández J. Use of fluorescent in situ hybridization to evidence the presence of Helicobacter pylori in water. Water Res. 2003; 37: 2251-2256.

19. Rimbara E, Sasatsu M, Graham DY. PCR detection of Helicobacter pylori in clinical samples. Methods Mol Biol. 2013; 943: 279-287.

Received : 01 Dec 2014
Accepted : 18 Mar 2015
Published : 06 Nov 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X